B. Wagenknecht et al., P53 ACCUMULATION PROMOTES DEPHOSPHORYLATION AND PROTEOLYTIC CLEAVAGE OF RETINOBLASTOMA PROTEIN IN HUMAN-MALIGNANT GLIOMA-CELLS, Cellular physiology and biochemistry, 7(6), 1997, pp. 304-311
The turner suppressor gene products, p53 and RE, modulate cellular res
ponses to genotoxic stress including cancer chemotherapy. Expression o
f the murine temperature-sensitive mutant p53(val135) in wild-type (32
.5 degrees C), but not mutant (38.5 degrees C), conformation results i
n complete growth arrest, but not apoptosis, in three human malignant
glioma cell lines, LN-18, LN-229 and LN-308. Here we report that force
d expression of p53(val135) promotes RB hypophosphorylation and proteo
lytic cleavage, generating a p68 pRB fragment. RE cleavage occurs both
with mutant and wild-type p53 conformation, Tn contrast to myeloid ce
lls, cleavage of RB is not associated with apoptosis in malignant glio
ma cells. Further, RE cleavage does not sensitize these cells to the c
ytotoxic effects of cytarabine or etoposide (VP-16). Established proap
optotic stimuli fur glioma cells such as exposure to CD95 ligand or do
xorubicin fail to induce cleavage of RE. Physiologically, RE is inacti
vated via CDK4-dependent phosphorylation, and CDK4 activity is control
led by the CDK inhibitor, CDKN2/MTS1/p16. The apparent lack of biologi
cal effects of RE cleavage in The glioma cells suggested consitutive i
nactivation of the Re pathway. Consistent with this hypothesis, we det
ected a homozygous loss of the CDKN2 alleles in LN-18 and LN-229 cells
and amplification of CDK4 in LN-308 cells, Further studies need to de
fine whether p53-mediated dephosphorylation and cleavage of,PB mediate
s apoptosis in cancer cells with an intact regulatory circuit involvin
g RE and the CDKN2/p16 and CDK4 proteins.